Pediatrix Medical Group (NYSE:MD) Posts Quarterly Earnings Results, Beats Estimates By $0.07 EPS

Pediatrix Medical Group (NYSE:MD) released its quarterly earnings data on Friday. The company reported $0.44 EPS for the quarter, topping the consensus estimate of $0.37 by $0.07, Briefing.com reports. Pediatrix Medical Group had a negative net margin of 12.58% and a positive return on equity of 10.59%. The business had revenue of $511.20 million for the quarter, compared to analyst estimates of $498.87 million. During the same period in the previous year, the firm earned $0.29 EPS. The business’s revenue for the quarter was up .9% compared to the same quarter last year.

Pediatrix Medical Group Trading Up 23.5 %

MD traded up $2.89 during trading on Friday, hitting $15.21. The company’s stock had a trading volume of 3,254,058 shares, compared to its average volume of 871,407. Pediatrix Medical Group has a twelve month low of $6.62 and a twelve month high of $15.42. The stock has a market cap of $1.31 billion, a PE ratio of -5.02, a PEG ratio of 1.96 and a beta of 1.56. The firm’s 50 day moving average price is $11.54 and its 200-day moving average price is $9.36. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.38 and a quick ratio of 1.38.

Insider Transactions at Pediatrix Medical Group

In related news, CFO C Marc Richards sold 32,562 shares of the company’s stock in a transaction on Friday, August 9th. The stock was sold at an average price of $10.08, for a total value of $328,224.96. Following the completion of the transaction, the chief financial officer now directly owns 192,785 shares in the company, valued at approximately $1,943,272.80. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, CEO James D. Swift sold 11,100 shares of Pediatrix Medical Group stock in a transaction on Friday, August 30th. The stock was sold at an average price of $10.79, for a total value of $119,769.00. Following the transaction, the chief executive officer now owns 170,001 shares in the company, valued at approximately $1,834,310.79. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO C Marc Richards sold 32,562 shares of the company’s stock in a transaction dated Friday, August 9th. The stock was sold at an average price of $10.08, for a total value of $328,224.96. Following the sale, the chief financial officer now owns 192,785 shares of the company’s stock, valued at $1,943,272.80. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 68,100 shares of company stock worth $701,889 over the last quarter. 2.00% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the stock. Truist Financial upped their price target on shares of Pediatrix Medical Group from $10.00 to $13.00 and gave the company a “hold” rating in a report on Monday, October 7th. StockNews.com upgraded Pediatrix Medical Group from a “sell” rating to a “hold” rating in a report on Wednesday, August 7th. UBS Group boosted their price target on Pediatrix Medical Group from $9.00 to $10.50 and gave the stock a “neutral” rating in a report on Friday, August 9th. Finally, Jefferies Financial Group raised Pediatrix Medical Group from a “hold” rating to a “buy” rating and increased their price objective for the company from $8.00 to $14.00 in a research note on Thursday, September 26th. Five equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $10.90.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.